NCT01870804View on ClinicalTrials.gov

Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury (PRATO-ACS 2)

PHASE4CompletedINTERVENTIONAL
Enrollment

760

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

July 31, 2016

Study Completion Date

September 30, 2016

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Rosuvastatin

DRUG

Atorvastatin

Trial Locations (1)

59100

Cardiology Division, Prato Hospital, Prato

All Listed Sponsors
lead

Centro Cardiopatici Toscani

OTHER

NCT01870804 - Atorvastatin Versus Rosuvastatin on Contrast Induced Acute Kidney Injury (PRATO-ACS 2) | Biotech Hunter | Biotech Hunter